Cutaneous sarcoidosis: current therapeutic modalities

References

• Wilson NJ, King CM. Cutaneous sarcoidosis. Postgrad. Med. J.74, 649–652 (1998).
   Google Scholar
• Newman LS, Rose CS, Maier LA. Sarcoidosis. N. Engl. J. Med.336, 1224–1234 (1997).
   PubMed Web of Science ®Google Scholar
• Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm. Venereol.72, 69–71 (1992).
   PubMed Web of Science ®Google Scholar
• Badgwell C, Rosen T. Cutaneous sarcoidosis therapy updated. J. Am. Acad. Dermatol.56, 69–83 (2007).
   PubMed Web of Science ®Google Scholar
• Green CM. Topical tacrolimus for the treatment of cutaneous sarcoidosis. Clin. Exp. Dermatol.32, 457–458 (2007).
   Google Scholar
• Bersani TA, Nichols CW. Intralesional triamcinolone for cutaneous palpebral sarcoidosis. Am. J. Ophthalmol.99, 561–562 (1985).
   Google Scholar
• Baughman RP, Lower EE. Evidence-based therapy for cutaneous sarcoidosis. Clin. Dermatol.25, 334–340 (2007).
   PubMed Web of Science ®Google Scholar
• Baughman RP, Lower EE. Therapy for extrapulmonary sarcoidosis. Semin. Respir. Crit. Care Med.23, 589–596 (2002).
   Google Scholar
• Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis – an analysis of 818 patients. Q. J. Med.208, 525–533 (1983).
   Google Scholar
• Paramothayan NS, Lasserson TJ, Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst. Rev.CD001114 (2005).
   Google Scholar
• Gibson GJ, Prescott RJ, Muers MF et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax51, 238–247 (1996).
   PubMed Web of Science ®Google Scholar
• White ES, Lynch JP. Current and emerging strategies for the management of sarcoidosis. Expert Opin. Phramacother.8, 1293–1311 (2007).
   PubMed Web of Science ®Google Scholar
• Baughman RP, Lower EE. Steroid-sparing alternative treatments for sarcoidosis. Clin. Chest Med.12, 139–160 (1997).
   Google Scholar
• Jones E, Callen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J. Am. Acad. Dermatol.23, 487–489 (1990).
   PubMed Web of Science ®Google Scholar
• Jones SK. Ocular toxicity and hydroxychloroquine: guidelines for screening. Br. J. Dermatol.140, 3–7 (1999).
   PubMed Web of Science ®Google Scholar
• Baughman RP, Lynch JP. Difficult treatment issues in sarcoidosis. J. Intern. Med.253, 41–45 (2003).
   PubMedGoogle Scholar
• Yesudian PD, Azurdia RM. Scar sarcoidosis following tattooing of the lips treated with mepacrine. Clin. Exp. Dermatol.29, 552–554 (2004).
   Google Scholar
• HughsJR, Pembroke AC. Cutaneous sarcoid treated with mecaprine. 19(5), 448 (1994).
   Google Scholar
• Liedtka JE. Intralesional chloroquine for the treatment of cutaneous sarcoidosis. Int. J. Dermatol.35, 682–683 (1996).
   Google Scholar
• Webster GF, Razsi LK, Sanchez M, Shupack JL. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J. Am. Acad. Dermatol.24, 451–454 (1991).
   PubMed Web of Science ®Google Scholar
• Duhra P. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis. J. Am. Acad. Dermatol.28, 466–469 (1993).
   PubMed Web of Science ®Google Scholar
• Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax54, 742–746 (1999).
   PubMed Web of Science ®Google Scholar
• Mosam A, Morar N. Recalcitrant cutaneous sarcoidosis: an evidence-based sequential approach. J. Dermatolog. Treat.15, 353–359 (2004).
   PubMedGoogle Scholar
• Moller DR. Treatment of sarcoidosis – from a basic science point of view. J. Intern. Med.253, 31–40 (2003).
   PubMed Web of Science ®Google Scholar
• Kouba DJ, Mimouni D, Rencic A, Nousari HC. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br. J. Dermatol.148, 147–148 (2003).
   PubMed Web of Science ®Google Scholar
• Wyser CP, van Schalkwyk EM, Alheit B, Bardin PG, Joubert JR. Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial. Am. J. Respir. Crit. Care Med.156, 1371–1376 (1997).
   PubMed Web of Science ®Google Scholar
• O’Callaghan CA, Wells AU, Lalvani A, Dhillon PD, Hansell DM, Mitchell DN. Effective use of ciclosporin in sarcoidosis: a treatment strategy based on computed tomography scanning. Eur. Respir. J.7, 2255–2256 (1994).
   PubMed Web of Science ®Google Scholar
• Kataria YP. Chlorambucil in sarcoidosis. Chest78, 36–43 (1980).
   PubMed Web of Science ®Google Scholar
• Israel HL, McComb BL. Chlorambucil treatment of sarcoidosis. Sarcoidosis8, 35–41 (1991).
   PubMedGoogle Scholar
• Mallbris L, Ljungberg A, Hedblad MA, Larsson P, Stahle-Backdahl M. Progressive cutaneous sarcoidosis responding to anti-tumour necrosis factor-α therapy. J. Am. Acad. Dermatol.48, 290–293 (2003).
   PubMed Web of Science ®Google Scholar
• Meyerle JH, Shorr A. The use of infliximab in cutaneous sarcoidosis. J. Drugs Dermatol.2, 413–414 (2003).
   PubMedGoogle Scholar
• Heffernan MP, Smith DI. Adalimumab for the treatment of cutaneous sarcoidosis. Arch. Dermatol.142, 17–19 (2006).
   PubMed Web of Science ®Google Scholar
• Philips MA, Lynch J, Azmi FH. Ulcerative cutaneous sarcoidosis responding to adalimumab. J. Am. Acad. Dermatol.53, 917 (2005).
   PubMed Web of Science ®Google Scholar
• Sweiss NJ, Curran J, Baughman RP. Sarcoidosis, role of tumour necrosis factor inhibitors and other biological agents, past, present, and future concepts. Clin. Dermatol.25, 341–346 (2007).
   Google Scholar
• Khanna D, Liebling MR, Louie JS. Etanercept ameliorates sarcoidosis arthritis and skin disease. J. Rheumatol.30, 1864–1867 (2003).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Lopez MA, Blanco R, Gonzalez-Vela MC, Fernandez-Llaca H, Rodriguez-Valverde V. Development of sarcoidosis during etanercept treatment. Arthritis Rheum.S15, 817–820 (2006).
   Google Scholar
• Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L. The use of tetracycline’s for the treatment of sarcoidosis. Arch. Dermatol.137, 69–73 (2001).
   PubMedGoogle Scholar
• Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracyclines, minocycline, and doxycycline. Arch. Dermatol.133, 1224–1230 (1997).
   PubMed Web of Science ®Google Scholar
• Baughman RP, Lower EE. Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents. Am. J. Clin. Dermatol.5, 385–394 (2004).
   PubMed Web of Science ®Google Scholar
• Baughman RP, Judson MA, Teirstein AS, Moller DR, Lower EE. Thalidomide for chronic sarcoidosis. Chest122, 227–232 (2002).
   PubMed Web of Science ®Google Scholar
• Waldinger TP, Ellis CN, Quint K, Voorhees JJ. Treatment of cutaneous sarcoidosis with isotretinoin. Arch. Dermatol.119, 1003–1005 (1983).
   PubMedGoogle Scholar
• Cagnoni ML, Lombardi A, Cerinic MC, Dedola GL, Pignone A. Melatonin for the treatment of chronic refractory sarcoidosis. Lancet346, 1229–1230 (1995).
   Google Scholar
• Pignone AM, Rosso AD, Fiori G, Matucci-Cerinic M, Becucci A, Tempestini A, Livi R et al. Melatonin is a safe and effective treatment for chronic pulmonary and extra-pulmonary sarcoidosis. J. Pineal Res.41, 95–100 (2006).
   PubMed Web of Science ®Google Scholar
• Brechtel B, Haas N, Henz BM, Kolde G. Allopurinol: a therapeutic alternative for disseminated cutaneous sarcoidosis. Br. J. Dermatol.135, 307–309 (1996).
   PubMedGoogle Scholar
• Bregnhoej A, Jemec GB. Low-dose allopurinol in the treatment of cutaneous sarcoidosis: response in four of seven patients. J. Dermatolog. Treat.16, 125–127 (2005).
   PubMed Web of Science ®Google Scholar
• Pollock JL. Sarcoidosis responding to allopurinol. Arch. Dermatol.116, 273–274 (1980).
   PubMedGoogle Scholar
• Nowack U, Gambichler T, Hanefeld C, Kastner U, Altmeyer P. Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters. BMC Dermatol.2, 15 (2002).
   Google Scholar
• Zabel P, Entzian P, Dalhoff K, Schlaak M. Pentoxifylline in treatment of sarcoidosis. Am. J. Respir. Crit. Care Med.155, 1665–1669 (1997).
   PubMed Web of Science ®Google Scholar
• Majithia V, Sanders S, Harisdangkul V. Wilson JG. Successful treatment of sarcoidosis with leflunomide. Rheumatology (Oxford)42, 700–702 (2003).
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay D. Exfoliative dermatitis induced by leflunomide therapy. J. Dermatol.30, 845–846 (2003).
   Google Scholar
• Yamada H, Ide A, Sugiura M, Tajima S. Treatment of cutaneous sarcoidosis with transilat. J. Dermatol.22, 149–152 (1995).
   Google Scholar
• Ridder GJ, Strohhacker H, Lohle E, Golz A, Fradis M. Laryngeal sarcoidosis: Treatment with the antileprosy drug clofazimine. Ann. Otol. Rhinol. Laryngol.109, 1146–1149 (2000).
   Google Scholar
• Karrer S, Abels C, Wimmershoff MB, Landthaler M, Szeimles RM. Successful treatment of cuatneous sarcoidosis using topical photodynamic therapy. Arch. Dermatol.138, 581–584 (2002).
   PubMedGoogle Scholar
• Patterson JW, Fitzwater JE. Treatment of hypopigmented sarcoidosis with 8-methoxypsoralen and long wave ultraviolet light. Int. J. Dermatol.21, 476–480 (1982).
   Google Scholar
• Mahnke N, Medve-Koenigs K, Berneburg M, Ruzicka T, Neumann NJ. Cutaneous sarcoidosis treated with medium-dose UVA1. J. Am. Acad. Dermatol.50, 978–979 (2004).
   Google Scholar
• Sterenbogh HCJM, van der Leun JC. Tumorgenesis by long wave-length UVA source. Photochem. Photobiol.51, 325–330 (1990).
   Google Scholar
• O’Donoghue NB, Barlow RJ. Laser remodeling of nodular nasal lupus pernio. Clin. Exp. Dermatol.31, 27–29 (2006).
   PubMed Web of Science ®Google Scholar
• Cliff S, Felix RH, Singh L, Harland CC. The successful treatment of lupus pernio with flashlamp pulsed dye laser. J. Cutan. Laser Ther.1, 49–52 (1999).
   PubMedGoogle Scholar
• Grema H, Greve B, Raulin C. Scar sarcoidosis – treatment with Q-switched ruby laser. Lasers Surg. Med.30, 398–400 (2002).
   PubMed Web of Science ®Google Scholar
• Green JJ, Lawrence N, Heymann WR. Generalised ulcerative sarcoidosis induced by therapy with flashlamp-pumped pulsed dye laser. Arch. Dermatol.137, 507–508 (2001).
   PubMedGoogle Scholar
• Frizzell B, Stith M, Jenrette J. Management of treatment – resistant cutaneous sarcoidosis with radiation. Am. J. Clin. Oncol.25, 573–575 (2002).
   PubMed Web of Science ®Google Scholar
• Goldin JH, Jawad SMA, Reid AP. Cutaneous nasal sarcoidosis – treatment by excision and split-skin grafting. J. Laryngol. Otol.97, 1053–1056 (1983).
   Google Scholar
• Gogstetter DS, Goldsmith LA. Treatment of cutaneous sarcoidosis using phonophoresis.J. Am. Acad. Dermatol.40, 767–769 (1999).
   Google Scholar